ArticleEuropean journal of human genetics : EJHG2012
A flexible likelihood framework for detecting associations with secondary phenotypes in genetic studies using selected samples: application to sequence data.
Article in European journal of human genetics : EJHG, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- A novel association test for multiple secondary phenotypes from a case-control GWAS.Genetic epidemiology · 2017Trial
- A Cautionary Note on the Effects of Population Stratification Under an Extreme Phenotype Sampling Design.Frontiers in genetics · 2019Article
- A hybrid likelihood model for sequence-based disease association studies.PLoS genetics · 2013Article
- SEQCHIP: a powerful method to integrate sequence and genotype data for the detection of rare variant associations.Bioinformatics (Oxford, England) · 2012Article
- A unified method for detecting secondary trait associations with rare variants: application to sequence data.PLoS genetics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
For most complex trait association studies using next-generation sequencing, in addition to the primary phenotype of interest, many clinically important secondary traits are also available, which can be analyzed to map susceptibility genes. Owing to high sequencing costs, most studies use selected samples, and the sampling mechanisms of these studies can be complicated. When the primary and secondary traits are correlated, analyses of secondary phenotypes can cause spurious associations in selected samples and existing methods are inadequate to adjust for them. To address this problem, a likelihood-based method, MULTI-TRAIT-ASSOCIATION (MTA) was developed. MTA is flexible and can be applied to any study with known sampling mechanisms. It also allows efficient inferences of genetic parameters. To investigate the power of MTA and different study designs, extensive simulations were performed under rigorous population genetic and phenotypic models. It is demonstrated that there are great benefits for analyzing secondary phenotypes in selected samples. In particular, using case-control samples and samples with extreme primary phenotypes can be more powerful than analyzing random samples of equivalent size. One major challenge for sequence-based association studies is that most data sets are not of sufficient size to be adequately powered. By applying MTA, data sets ascertained under distinct mechanisms or targeted at different primary traits can be jointly analyzed to map common phenotypes and greatly increase power. The combined analysis can be performed using freely available data sets from public repositories, for example, dbGaP. In conclusion, MTA will have an important role in dissecting the etiology of complex traits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.